Inhibamet 12,5/1000 mg 30 tablets

Inhibamet 12,5/1000 mg 30 tablets

Description

The drug is a combination drug used to treat type 2 diabetes.

Composition

- Alogliptin - 12.5 mg

- Metformin - 1000 mg

Pharmacological properties

• Combined hypoglycemic effect:
o Metformin acts primarily on insulin resistance.
o Alogliptin - on insulin stimulation and glucagon suppression in response to food intake.
• Does not cause hypoglycemia when used in monotherapy (except in cases of combined use with other drugs that lower glucose).

Method of administration

• Usually taken twice a day with meals.
• The dosage is selected individually by a doctor based on the level of glycemia and tolerance.

The use of the drug is prohibited without consulting a specialist doctor in the following cases:

Hypersensitivity to any of the components of the drug.

Patients with diabetic ketoacidosis.